1993
DOI: 10.1155/1994/801012
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated Mycobacterium chelonae Infection Presenting as Progressive Multifocal Osteomyelitis: Report of Two Cases and a Review of the Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…Mortality associated with localised infection is very rare, but there have been case reports previously of mortality with disseminated infection 11. Particularly patients who are immune suppressed are prone to prolonged periods of morbidity or mortality with disseminated spread of this infection.…”
Section: Outcome and Follow-upmentioning
confidence: 99%
“…Mortality associated with localised infection is very rare, but there have been case reports previously of mortality with disseminated infection 11. Particularly patients who are immune suppressed are prone to prolonged periods of morbidity or mortality with disseminated spread of this infection.…”
Section: Outcome and Follow-upmentioning
confidence: 99%
“…The most common clinical manifestation encountered with Mycobacterium chelonae is localized soft tissue infections in immunocompetent hosts [ 1 ]. These infections typically are sporadic and tend to occur at sites of trauma such as penetrating injury or surgical incision [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…The most common clinical manifestation encountered with Mycobacterium chelonae is localized soft tissue infections in immunocompetent hosts [ 1 ]. These infections typically are sporadic and tend to occur at sites of trauma such as penetrating injury or surgical incision [ 1 ]. Less commonly, disseminated infections may occur on a background of immunosuppression caused by medications (anti-tumor necrosis factor therapy, corticosteroids, and methotrexate) or diseases (AIDS, malignancy) [ [2] , [3] , [4] ].…”
Section: Introductionmentioning
confidence: 99%